查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2146944

經導管三尖瓣置換系統市場：全球市場預測，2026-2032年

Transcatheter Tricuspid Valve Replacement System Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，經導管三尖瓣置換系統市場將成長至 38.4 億美元，複合年成長率為 5.32%。

主要市場統計數據
基準年 2025 26.7億美元
預計年份：2026年 28.1億美元
預測年份 2032 38.4億美元
複合年成長率 (%) 5.32%

經導管三尖瓣置換術：臨床應用進展

經導管三尖瓣置換系統以導管植入而非開胸手術治療三尖瓣逆流。隨著臨床醫生尋求為老年患者、合併複雜基礎疾病的患者或手術風險較高的患者提供創傷較小的治療方案，該領域不斷發展。臨床研發的重點仍是手術安全性、瓣膜耐久性、病患選擇、影像學檢查以及顯著的功能改善證據。

證據、病患選擇和工作流程正在改變格局。

該領域的研究格局正從最初的可行性檢驗轉向更有系統的臨床評估和多學科治療路徑。3D心臟超音波圖、電腦斷層掃描（CT）、輸送系統以及術中影像技術的進步，提高了解剖評估和器械定位的準確性。此療法的廣泛應用取決於持續的治療效果、可控的併發症、可重複的植入手術、心臟團隊的專業水平、術後後續觀察以及與右心臟衰竭及相關疾病治療的整合。

人工智慧增強了影像診斷、規劃和後續治療。

人工智慧 (AI) 透過輔助影像分割、解剖測量、患者風險分層和手術規劃，推動了該領域的累積發展。機器學習工具可以幫助識別合格的患者，並規範各機構間對觀察的解讀；同時，監測應用可以幫助監測病情後續觀察並檢測惡化。這些優勢依賴於代表性的臨床數據、外部檢驗、臨床醫生監督、網路安全以及透明的效能評估。人工智慧並非旨在取代心臟團隊的判斷或前瞻性臨床證據。

區域性見解：準備程度的差異反映了證據和基礎設施的差異。

北美地區擁有先進的結構性心臟病診療計畫、尖端的影像技術和積極的臨床評估。歐洲則將成熟的經導管介入技術與嚴格的醫療技術評估以及各國特有的醫保報銷機制結合。亞太地區雖然部分市場擁有強大的三級醫療體系，但在醫療服務可近性、培訓和監管流程方面仍存在顯著差異。拉丁美洲的專科循環系統中心正在發展，但面臨成本和病患轉診方面的挑戰。中東地區正在主要大都市建立先進的醫院系統，而非洲的醫療水準仍然參差不齊，許多地區的專科醫療基礎設施有限，但該地區在建立區域轉診網路和培訓夥伴關係方面潛力巨大。

群體洞察：合作與監理塑造准入

東協市場心血管基礎設施水準存在差異，這為聯合訓練、病患轉診協調和評估標準統一提供了契機。金磚國家擁有大規模的患者群體，且監管、生產和醫院能力各不相同，因此在地化的證據和准入策略至關重要。歐盟雖然受益於跨國科學合作，但國家健保報銷政策仍具有重大影響。七國集團成員國普遍擁有先進的影像技術、專業團隊及臨床研究能力。海灣合作理事會成員國正在投資重症患者醫院服務，並可作為區域治療中心。北約成員國的醫療保健體系各不相同，但可以透過聯合研究和通用臨床標準來支持能力建構。

國家概況：成熟醫療體系和新興醫療體系的能力存在差異。

澳洲、加拿大、法國、德國、義大利、日本、韓國、英國、英國和美國擁有強大的心血管醫療體系，但各國在核准流程、保險報銷、轉診模式和證據要求方面存在差異。中國和印度的臨床需求龐大，醫療設備生態系統發展迅速，但主要都市區與資源匱乏地區之間存在顯著差距。巴西和墨西哥有重要的三級醫療機構，但醫療服務取得不均衡，且面臨經濟限制。俄羅斯擁有專業的心血管專家，但監管和供應方面的挑戰可能會影響醫療設備的供應。在所有國家，訓練有素的心臟醫療團隊、影像檢查、外科手術支援系統、長期登記系統和明確的轉診標準對於政策的成功至關重要。

領導者的行動重點：同時建立證據蒐集和執行能力。

行業領導者應優先考慮可靠的對比證據、透明的併發症報告以及長期耐久性追蹤研究。他們還應根據解剖結構的多樣性調整設備設計，投資於循環系統教育和培訓，並與心臟科醫生、外科醫生、放射科醫生和心臟衰竭專家合作，制定標準化的患者選擇方案。與醫院和註冊機構建立合作關係可以增強真實世界證據，與當地監管機構和保險報銷機構合作可以明確臨床價值。負責任的AI部署應利用檢驗的資料集、人工審核、可解釋的輸出以及部署後監測。准入策略應包括訓練、轉診網路以及適合資源受限環境的服務模式。

調查方法：建構和整合臨床和機構證據。

本執行摘要整合了經導管三尖瓣置換系統市場範圍內的既定評估維度，包括臨床證據、手術技能、影像學、法規、報銷、基礎設施、人力資源和區域準備。摘要以定性方式呈現區域、群體和國家層面的具體觀察結果，避免未經證實的數值論點。解讀重點在於結構性心臟病治療領域檢驗的趨勢，並區分當前能力和需要進一步臨床檢驗的領域。本摘要不包含市場估計值、市場規模、市場佔有率或預測。

結論：確鑿的證據和公平的實施對於取得進展至關重要。

經導管三尖瓣置換術正作為結構性心臟病微創治療轉型的一部分而不斷發展。其長期應用的關鍵不在於手術本身的新穎性，而是持續的臨床效益、安全且可重複的手術流程、嚴格的患者篩選以及永續的追蹤。那些能夠將實證醫學研究與人才培養、影像技術、數位化工具的合理運用以及符合當地實際情況的診療模式相結合的領導者，將更有利於推動該技術在臨床上取得實質進展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 經導管三尖瓣置換系統市場：依產品類型分類

  • 球囊擴張型
  • 自膨脹

第8章 經導管三尖瓣置換系統市場：依介入方式分類

  • 經股動脈
  • 經肝
  • 經頸靜脈法

第9章：經導管三尖瓣置換系統市場：依適應症分類

  • 原發性三尖瓣逆流
  • 繼發性續發性逆流

第10章：經導管三尖瓣置換系統市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 當地醫院
    • 三級醫療醫院

第11章 經導管三尖瓣置換系統市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 經導管三尖瓣置換系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 經導管三尖瓣置換系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • 4C Medical Technologies, Inc.
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Corcym
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • NaviGate Cardiac Structures, LLC
  • Peijia Medical Co., Ltd.
  • Trisol Medical Ltd.
  • Venus Medtech
  • WL Gore & Associates, Inc.

第16章 主要專家

Product Code: MRR-3D150775E4BB

The Transcatheter Tricuspid Valve Replacement System Market is projected to grow by USD 3.84 billion at a CAGR of 5.32% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.67 billion
Estimated Year [2026] USD 2.81 billion
Forecast Year [2032] USD 3.84 billion
CAGR (%) 5.32%

Transcatheter Tricuspid Valve Replacement Moves Toward Clinical Adoption

Transcatheter tricuspid valve replacement systems address tricuspid regurgitation through catheter-based implantation rather than open-heart surgery. The field is advancing as clinicians seek less invasive options for patients who are older, medically complex, or considered high risk for surgery. Clinical development remains centered on procedural safety, valve durability, patient selection, imaging, and evidence of meaningful functional improvement.

Evidence, Patient Selection, and Workflow Are Reshaping the Landscape

The landscape is shifting from early feasibility toward more structured clinical evaluation and multidisciplinary treatment pathways. Advances in three-dimensional echocardiography, computed tomography, delivery systems, and procedural imaging are improving anatomical assessment and device positioning. Adoption will depend on durable outcomes, manageable complications, reproducible implantation, heart-team expertise, post-procedure surveillance, and integration with treatment for right-heart failure and related conditions.

Artificial Intelligence Strengthens Imaging, Planning, and Follow-Up

Artificial intelligence is contributing to the cumulative development of this field by supporting image segmentation, anatomical measurements, patient-risk stratification, and procedure planning. Machine-learning tools may help identify suitable candidates and standardize interpretation across centers, while monitoring applications can assist with follow-up and detection of deterioration. These benefits remain dependent on representative clinical data, external validation, clinician oversight, cybersecurity, and transparent performance assessment; AI does not replace heart-team judgment or prospective clinical evidence.

Regional Insights: Uneven Readiness Reflects Evidence and Infrastructure

North America is characterized by advanced structural-heart programs, sophisticated imaging capabilities, and active clinical evaluation. Europe combines established transcatheter expertise with rigorous health-technology assessment and variation in national reimbursement pathways. Asia-Pacific presents strong tertiary-care capacity in selected markets alongside substantial differences in access, training, and regulatory processes. Latin America is developing specialized cardiovascular centers but faces affordability and referral challenges. The Middle East is building advanced hospital capacity in major urban systems, while Africa remains highly heterogeneous, with limited specialist infrastructure in many settings and opportunities for regional referral networks and training partnerships.

Group Insights: Cooperation and Regulation Shape Access

ASEAN markets show differing levels of cardiovascular infrastructure, creating opportunities for shared training, referral coordination, and harmonized evaluation. BRICS countries combine large patient populations with varied regulatory, manufacturing, and hospital capabilities, making local evidence and access strategies important. The European Union benefits from cross-border scientific collaboration while national reimbursement decisions remain consequential. G7 members generally offer advanced imaging, specialist teams, and clinical research capacity. GCC states are investing in high-acuity hospital services and can serve as regional treatment hubs. NATO members span diverse health systems, but collaborative research and shared clinical standards can support capability development.

Country Insights: Capability Varies Across Established and Emerging Systems

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States possess strong specialist cardiovascular capabilities, although approval, reimbursement, referral patterns, and evidence requirements differ. China and India combine substantial clinical demand with rapidly developing medical-device ecosystems and pronounced variation between leading urban centers and less-resourced regions. Brazil and Mexico have important tertiary-care institutions but face uneven access and affordability constraints. Russia has specialized cardiovascular expertise alongside regulatory and supply considerations that can affect availability. Across all countries, successful implementation requires trained heart teams, imaging access, surgical backup, longitudinal registries, and clear referral criteria.

Action Priorities for Leaders: Build Evidence and Delivery Capability Together

Industry leaders should prioritize robust comparative evidence, transparent reporting of complications, and long-term durability follow-up. They should align device design with anatomical diversity, invest in imaging education and proctoring, and develop standardized patient-selection protocols with cardiologists, surgeons, imagers, and heart-failure specialists. Partnerships with hospitals and registries can improve real-world evidence, while local regulatory and reimbursement engagement can clarify clinical value. Responsible AI deployment should use validated datasets, human review, explainable outputs, and post-deployment monitoring. Access strategies should include training, referral networks, and service models suited to resource-constrained settings.

Research Methodology: Structured Synthesis of Clinical and System Evidence

This executive summary uses the defined market scope of transcatheter tricuspid valve replacement systems and synthesizes established dimensions of evaluation: clinical evidence, procedural technology, imaging, regulation, reimbursement, infrastructure, workforce, and geographic readiness. Regional, group, and country observations are framed qualitatively and avoid unsupported numerical claims. Interpretation emphasizes verifiable trends in structural-heart care and distinguishes current capabilities from areas requiring further clinical validation. No market estimates, market sizing, market shares, or forecasts are included.

Conclusion: Durable Evidence and Equitable Implementation Will Determine Progress

Transcatheter tricuspid valve replacement is progressing within a broader shift toward less invasive structural-heart treatment. Its long-term role will depend less on procedural novelty alone than on durable clinical benefit, safe and reproducible delivery, careful patient selection, and sustainable follow-up. Leaders that combine evidence generation with workforce development, imaging capability, responsible digital tools, and regionally appropriate access models will be best positioned to support clinically meaningful adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Transcatheter Tricuspid Valve Replacement System Market, by Product Type

  • 7.1. Introduction
  • 7.2. Balloon-Expandable
  • 7.3. Self-Expanding

8. Transcatheter Tricuspid Valve Replacement System Market, by Interventional Approach

  • 8.1. Introduction
  • 8.2. Transfemoral
  • 8.3. Transhepatic
  • 8.4. Transjugular

9. Transcatheter Tricuspid Valve Replacement System Market, by Indication

  • 9.1. Introduction
  • 9.2. Primary Tricuspid Regurgitation
  • 9.3. Secondary Tricuspid Regurgitation

10. Transcatheter Tricuspid Valve Replacement System Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centers
  • 10.3. Hospitals
    • 10.3.1. Community Hospitals
    • 10.3.2. Tertiary Care Hospitals

11. Transcatheter Tricuspid Valve Replacement System Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Transcatheter Tricuspid Valve Replacement System Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Transcatheter Tricuspid Valve Replacement System Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. 4C Medical Technologies, Inc.
  • 15.2. Abbott Laboratories
  • 15.3. Boston Scientific Corporation
  • 15.4. Corcym
  • 15.5. Edwards Lifesciences Corporation
  • 15.6. JenaValve Technology, Inc.
  • 15.7. LivaNova PLC
  • 15.8. Medtronic plc
  • 15.9. Meril Life Sciences Pvt. Ltd.
  • 15.10. MicroPort Scientific Corporation
  • 15.11. NaviGate Cardiac Structures, LLC
  • 15.12. Peijia Medical Co., Ltd.
  • 15.13. Trisol Medical Ltd.
  • 15.14. Venus Medtech
  • 15.15. W.L. Gore & Associates, Inc.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Transcatheter Tricuspid Valve Replacement System Market, Years Considered for the Study
  • FIGURE 2. Global Transcatheter Tricuspid Valve Replacement System Market, Research Design
  • FIGURE 3. Global Transcatheter Tricuspid Valve Replacement System Market, Research Framework
  • FIGURE 4. Global Transcatheter Tricuspid Valve Replacement System Market, Data Triangulation
  • FIGURE 5. Global Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2025 vs 2032 (%)
  • FIGURE 9. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2025 vs 2032 (%)
  • FIGURE 11. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Transcatheter Tricuspid Valve Replacement System Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Transcatheter Tricuspid Valve Replacement System Market Segmentation & Coverage
  • TABLE 2. Global Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Balloon-Expandable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Balloon-Expandable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Balloon-Expandable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Self-Expanding Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Self-Expanding Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Self-Expanding Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 11. Global Transfemoral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global Transfemoral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global Transfemoral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global Transhepatic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Transhepatic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Transhepatic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Transjugular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Transjugular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Transjugular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 21. Global Primary Tricuspid Regurgitation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 22. Global Primary Tricuspid Regurgitation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 23. Global Primary Tricuspid Regurgitation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 24. Global Secondary Tricuspid Regurgitation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 25. Global Secondary Tricuspid Regurgitation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 26. Global Secondary Tricuspid Regurgitation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 27. Global Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 28. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Community Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Community Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Community Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Tertiary Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Tertiary Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Tertiary Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Asia-Pacific Transcatheter Tricuspid Valve Replacement System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Asia-Pacific Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 43. Asia-Pacific Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 44. Asia-Pacific Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 45. Asia-Pacific Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 46. Asia-Pacific Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 47. North America Transcatheter Tricuspid Valve Replacement System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. North America Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 49. North America Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 50. North America Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 51. North America Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 52. North America Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 53. Latin America Transcatheter Tricuspid Valve Replacement System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Latin America Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 55. Latin America Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 56. Latin America Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 57. Latin America Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 58. Latin America Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 59. Europe Transcatheter Tricuspid Valve Replacement System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Europe Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 61. Europe Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 62. Europe Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 63. Europe Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 64. Europe Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 65. Middle East Transcatheter Tricuspid Valve Replacement System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Middle East Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 67. Middle East Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 68. Middle East Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 69. Middle East Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 70. Middle East Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 71. Africa Transcatheter Tricuspid Valve Replacement System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Africa Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 73. Africa Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 74. Africa Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 75. Africa Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 76. Africa Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 77. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 78. ASEAN Transcatheter Tricuspid Valve Replacement System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. ASEAN Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 80. ASEAN Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 81. ASEAN Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 82. ASEAN Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 83. ASEAN Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 84. GCC Transcatheter Tricuspid Valve Replacement System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. GCC Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 86. GCC Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 87. GCC Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 88. GCC Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 89. GCC Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 90. European Union Transcatheter Tricuspid Valve Replacement System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. European Union Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 92. European Union Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 93. European Union Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 94. European Union Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 95. European Union Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 96. BRICS Transcatheter Tricuspid Valve Replacement System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. BRICS Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 98. BRICS Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 99. BRICS Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 100. BRICS Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 101. BRICS Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 102. G7 Transcatheter Tricuspid Valve Replacement System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 103. G7 Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 104. G7 Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 105. G7 Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 106. G7 Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 107. G7 Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 108. NATO Transcatheter Tricuspid Valve Replacement System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 109. NATO Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 110. NATO Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 111. NATO Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 112. NATO Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 113. NATO Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 114. Global Transcatheter Tricuspid Valve Replacement System Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 115. United States Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 116. United States Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 117. United States Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 118. United States Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 119. United States Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 120. United States Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 121. Canada Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 122. Canada Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 123. Canada Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 124. Canada Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 125. Canada Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 126. Canada Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 127. Mexico Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 128. Mexico Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 129. Mexico Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 130. Mexico Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 131. Mexico Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 132. Mexico Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 133. Brazil Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 134. Brazil Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 135. Brazil Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 136. Brazil Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 137. Brazil Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 138. Brazil Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 139. United Kingdom Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 140. United Kingdom Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 141. United Kingdom Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 142. United Kingdom Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 143. United Kingdom Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 144. United Kingdom Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 145. Germany Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 146. Germany Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 147. Germany Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 148. Germany Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 149. Germany Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 150. Germany Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 151. France Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 152. France Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 153. France Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 154. France Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 155. France Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 156. France Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 157. Russia Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 158. Russia Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 159. Russia Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 160. Russia Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 161. Russia Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 162. Russia Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 163. Italy Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 164. Italy Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 165. Italy Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 166. Italy Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 167. Italy Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 168. Italy Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 169. Spain Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 170. Spain Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 171. Spain Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 172. Spain Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 173. Spain Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 174. Spain Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 175. China Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 176. China Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 177. China Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 178. China Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 179. China Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 180. China Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 181. India Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 182. India Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 183. India Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 184. India Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 185. India Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 186. India Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 187. Japan Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 188. Japan Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 189. Japan Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 190. Japan Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 191. Japan Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 192. Japan Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 193. Australia Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 194. Australia Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 195. Australia Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 196. Australia Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 197. Australia Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 198. Australia Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 199. South Korea Transcatheter Tricuspid Valve Replacement System Market Size, 2017-2032 (USD Million)
  • TABLE 200. South Korea Transcatheter Tricuspid Valve Replacement System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 201. South Korea Transcatheter Tricuspid Valve Replacement System Market Size, by Interventional Approach, 2017-2032 (USD Million)
  • TABLE 202. South Korea Transcatheter Tricuspid Valve Replacement System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 203. South Korea Transcatheter Tricuspid Valve Replacement System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 204. South Korea Transcatheter Tricuspid Valve Replacement System Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 205. Global Transcatheter Tricuspid Valve Replacement System Market Share, by Key Player, 2025
  • TABLE 206. Global Transcatheter Tricuspid Valve Replacement System Market, Key Experts